We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
China Pharma Holdings Inc | AMEX:CPHI | AMEX | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.0181 | -5.69% | 0.3002 | 204 | 09:51:35 |
Nevada
|
001-34471
|
73-1564807
|
(State or other jurisdiction
of Incorporation)
|
(Commission File No.)
|
(IRS Employer
Identification No.)
|
|
|
|
2.
|
A proposal to approve, on a non-binding, advisory basis, the compensation of our named executive officer as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission.
|
For
|
|
Against
|
|
Abstain
|
|
24,895,511
|
|
2,347,574
|
|
58,500
|
|
3.
|
A proposal to approve, on a non-binding, advisory basis, the frequency of the advisory vote on executive compensation:
|
One Year
|
|
Two Years
|
Three Years
|
|
Abstain
|
|
7,698,383
|
|
11,445
|
19,558,977
|
|
2,780
|
|
|
CHINA PHARMA HOLDINGS, INC.
By: /s/ Zhilin Li
Name: Zhilin Li
Title: President and Chief Executive Officer
|
1 Year China Pharma Chart |
1 Month China Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions